GlobalData on MSN2d
Medtronic announces two-year trial outcomes of Evolut TAVR
Medtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.
MassDevice2d
Medtronic has positive TAVR results in small aortic annulus patients
Medtronic released positive two-year trial Evolut TAVR results that demonstrated superior valve performance in small aortic ...
Zacks.com on MSN2d
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.
Kalkine Media2d
Medtronic’s SMART Trial Shows Evolut TAVR Outperforms SAPIEN in Key Long-Term Outcomes
Highlights,Evolut TAVR demonstrated significantly lower rates of bioprosthetic valve dysfunction (BVD) compared to SAPIEN at ...
Medtronic releases two-year results of SMART trial for TAVR
Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...
BioWorld1d
Medtronic sees SMART TAVR results in small aortic annulus patients
Medtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or ...
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
PharmiWeb2d
SMART Trial two-year data continues to demonstrate…
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
Nasdaq2d
Medtronic : Data Confirms Superior Valve Performance Of Evolut TAVR System In Small Annulus Patients
(RTTNews) - Medtronic plc (MDT ... as measured by bioprosthetic valve dysfunction (BVD) at two years for Evolut TAVR compared to SAPIEN. The SMART two-year data demonstrated that Evolut TAVR ...
Medindia4d
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR system in small annulus patients
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...
Nasdaq2d
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
Per the latest update, the Evolut FX+ TAVR system is seeing strong uptake in the United States, with international expansion progressing well. With favorable trial results, Medtronic’s ...